FDA Approves Neurotech Company for Testing Brain Chip in Humans

 

Activist Post reports that brain-computer interface, or BCI, represents the latest frontier of artificial intelligence and biology. While this technology is still early in development, a growing number of companies are already looking at its commercial applications.

On July 28, one of those companies, New York startup Synchron, received FDA approval to test its brain device in human patients. Stentrode, Synchron’s implantable device is small enough to be implanted via a blood vessel at the base of the neck. The device is then maneuvered toward a vessel in the brain.

Stentrode works by communicating through a tiny wire with a second implant in the chest. A transmitter then sends signals to an external computer near the patient.

“We have worked together to pave a pathway forward, towards the first commercial approval for a permanently implanted BCI for the treatment of paralysis”, Thomas Oxley, Synchron CEO, said via Activist Post.

The company plans to enroll six patients in its U.S. trial later this year. According to Oxley, the U.S. study will take a closer look at safety issues, including physical risks and cybersecurity. Activist Post reports an FDA-approved product could be on the market in as soon as 3 to 5 years.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

private equity
Alts Innovators: UT Austin’s Dr. Ken Wiles on Private Equity
December 15, 2025

Private equity is entering a period of adjustment after decades of expansion fueled by falling interest rates and abundant capital. That long-running tailwind reversed beginning in 2022, when interest rates rose sharply, disrupting deal activity, slowing exits, and bringing renewed attention to a long-standing vulnerability in private markets: liquidity. Industry reports have highlighted softer fundraising,…

Read More
SPD
Getting SPD Teams to the Table: Why Sterile Processing Deserves a Central Role in Surgical Planning and Operations
December 15, 2025

Sterile Processing Departments (SPDs) remain the backbone of safe surgical care, yet across the country, they’re still routinely left out of early decision-making around products, construction, staffing, and case planning. As hospitals juggle tighter margins, higher patient acuity, and growing procedural demands, the consequences of excluding SPD voices become unmistakably real—showing up in daily…

Read More
WireXpert
WireXpert MP Wire Mapping Overview
December 13, 2025

In modern network installations, speed alone isn’t enough—precision is what keeps systems reliable and downtime low. Tools like the WireXpert MP cable certifier reflect how far copper cable diagnostics have evolved, moving beyond simple pass-or-fail testing into actionable insight. By running a full 500 MHz sweep on a Category 6A link, technicians can…

Read More
Why Connectivity Has Become the Cornerstone of Modern Industrial Automation
December 11, 2025

Industrial automation is in the middle of a profound shift, as manufacturers push beyond basic control toward fully connected, data-driven operations that bridge the plant floor and the enterprise. What began years ago as early experiments in digital transformation—simply getting PLC data into IT systems—has now accelerated into a critical business imperative fueled by…

Read More